JP2003517831A - 感受性物質のカプセル化 - Google Patents

感受性物質のカプセル化

Info

Publication number
JP2003517831A
JP2003517831A JP2001546771A JP2001546771A JP2003517831A JP 2003517831 A JP2003517831 A JP 2003517831A JP 2001546771 A JP2001546771 A JP 2001546771A JP 2001546771 A JP2001546771 A JP 2001546771A JP 2003517831 A JP2003517831 A JP 2003517831A
Authority
JP
Japan
Prior art keywords
sensitive material
solid support
volatile
encapsulation
sensitive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001546771A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003517831A5 (enExample
Inventor
カール ジェイ パシフィコ
ウェン−シン ウ
マルタ フラリー
Original Assignee
バルケム コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バルケム コーポレイション filed Critical バルケム コーポレイション
Publication of JP2003517831A publication Critical patent/JP2003517831A/ja
Publication of JP2003517831A5 publication Critical patent/JP2003517831A5/ja
Pending legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
    • A23L27/12—Natural spices, flavouring agents or condiments; Extracts thereof from fruit, e.g. essential oils
    • A23L27/13—Natural spices, flavouring agents or condiments; Extracts thereof from fruit, e.g. essential oils from citrus fruits
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72—Encapsulation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/75—Fixation, conservation, or encapsulation of flavouring agents the flavouring agents being bound to a host by chemical, electrical or like forces, e.g. use of precursors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/77—Use of inorganic solid carriers, e.g. silica
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Glanulating (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Lubricants (AREA)
JP2001546771A 1999-12-22 2000-12-13 感受性物質のカプセル化 Pending JP2003517831A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/469,368 US6251478B1 (en) 1999-12-22 1999-12-22 Sensitive substance encapsulation
US09/469,368 1999-12-22
PCT/US2000/033673 WO2001045835A1 (en) 1999-12-22 2000-12-13 Sensitive substance encapsulation

Publications (2)

Publication Number Publication Date
JP2003517831A true JP2003517831A (ja) 2003-06-03
JP2003517831A5 JP2003517831A5 (enExample) 2008-02-14

Family

ID=23863520

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001546771A Pending JP2003517831A (ja) 1999-12-22 2000-12-13 感受性物質のカプセル化

Country Status (10)

Country Link
US (2) US6251478B1 (enExample)
EP (2) EP1433525A1 (enExample)
JP (1) JP2003517831A (enExample)
KR (1) KR20020095172A (enExample)
CN (1) CN1413125A (enExample)
AU (1) AU780513C (enExample)
CA (1) CA2394520A1 (enExample)
MX (1) MXPA02006202A (enExample)
NZ (1) NZ519521A (enExample)
WO (1) WO2001045835A1 (enExample)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006527739A (ja) * 2003-06-18 2006-12-07 リポフーズ，エセ．エレ． 活性成分の投与のためのマイクロカプセル
JP2007532543A (ja) * 2004-04-07 2007-11-15 レスベラトロル パートナーズ， エルエルシー 栄養補助サプリメントおよびそれを処理する方法
JP2008510695A (ja) * 2004-08-20 2008-04-10 フイルメニツヒ ソシエテ アノニム フレーバー又はフレグランス成分又は組成物を炭水化物マトリックス中に導入する方法
JP2010090195A (ja) * 2008-10-03 2010-04-22 Mohan Sharad 固形石鹸及びこれを用いた送達方法
JP2012503474A (ja) * 2008-09-24 2012-02-09 ボングレン エス．アー． チーズ又はチーズ製品を製造する方法及び装置
JP2012055288A (ja) * 2010-09-13 2012-03-22 Kaneka Corp 安定化された生菌製剤およびその製造方法。
JP2012523462A (ja) * 2009-04-13 2012-10-04 キュアマーク リミテッド ライアビリティ カンパニー 酵素送達システムならびに調製方法および使用方法
US8916528B2 (en) 2011-11-16 2014-12-23 Resveratrol Partners, Llc Compositions containing resveratrol and nucleotides
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
US9624525B2 (en) 1999-12-17 2017-04-18 Curemark, Llc Method for treating pervasive development disorders
US9687535B2 (en) 2008-10-03 2017-06-27 Curemark, Llc Methods and compositions for the treatment of symptoms of prion diseases
US9687534B2 (en) 2008-04-18 2017-06-27 Curemark, Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
KR101804284B1 (ko) * 2015-09-24 2017-12-14 학교법인연세대학교 프로바이오틱 유산균을 함유하는 우유과자의 제조방법
US9895427B2 (en) 2009-01-06 2018-02-20 Galenagen, Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
US9925250B2 (en) 2008-03-13 2018-03-27 Curemark, Llc Method of treating proteinuria in pregnancy
US10209253B2 (en) 2000-11-16 2019-02-19 Curemark, Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US10279016B2 (en) 2011-04-21 2019-05-07 Curemark, Llc Method of treatment of schizophreniform disorder
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US10350229B2 (en) 2005-08-30 2019-07-16 Curemark, Llc Use of lactulose in the treatment of autism
US10588948B2 (en) 2008-06-26 2020-03-17 Curemark, Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US10736946B2 (en) 2009-01-06 2020-08-11 Galenagen, Llc Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US11016104B2 (en) 2008-07-01 2021-05-25 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
US12226464B2 (en) 2017-04-10 2025-02-18 Curemark, Llc Compositions for treating addiction

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756405B2 (en) * 2000-04-18 2004-06-29 Natural Asa Conjugated linoleic acid powder
US20030149288A1 (en) * 2000-04-18 2003-08-07 Natural Asa Conjugated linoleic acid powder
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US7070820B2 (en) * 2000-10-02 2006-07-04 Novozymes A/S Coated particles containing an active
ES2187380A1 (es) * 2001-11-16 2003-06-01 Sanchez Juan Balufo Mejoras introducidas en productos destinados al consumo humano o animal.
US20030175382A1 (en) * 2002-03-14 2003-09-18 Dally Vernetta L. Heat released encapsulated yeast
ATE339114T1 (de) 2002-07-23 2006-10-15 Wrigley W M Jun Co Verkapselte aromastoffe und kaugummi damit
AU2003269660A1 (en) * 2002-10-21 2004-05-04 Givaudan Sa Pesticidal compositions
US6835397B2 (en) 2002-12-23 2004-12-28 Balchem Corporation Controlled release encapsulated bioactive substances
EP1639108A2 (en) 2003-02-28 2006-03-29 McGILL UNIVERSITY Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides
EP1462013A1 (de) * 2003-03-27 2004-09-29 Cognis Iberia, S.L. Mikrokapseln, bestehend aus einer Hüllmembran und einer Hydroxytyrosol enthaltenden Matrix
EP2926668B1 (en) 2003-04-11 2020-07-29 Cargill, Incorporated Pellet systems for preparing beverages
US7744943B2 (en) * 2003-05-12 2010-06-29 Grand Brands, LLC Edible mix and method of making the same
US20050181019A1 (en) * 2003-07-03 2005-08-18 Slim-Fast Foods Company, Division Of Conopco, Inc. Nutrition bar
EP1659885B1 (en) 2003-08-11 2013-01-16 Oragenics, Inc. Compositions in the maintenance of oral health
CN1302112C (zh) * 2003-09-17 2007-02-28 广东肇庆星湖生物科技股份有限公司 利用毕赤酵母生产高比活耐高温植酸酶
WO2005089564A1 (en) * 2004-03-19 2005-09-29 Danisco A/S Emulsifier composition for shortening
US20050271609A1 (en) * 2004-06-08 2005-12-08 Colgate-Palmolive Company Water-based gelling agent spray-gel and its application in personal care formulation
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
US20060115553A1 (en) * 2004-12-01 2006-06-01 Slim-Fast Foods Company, Division Of Conopco, Inc. Nutrition bar or other food product and process of making
US20060228448A1 (en) * 2005-04-11 2006-10-12 The Iams Company Pet food compositions comprising two components
US7700142B2 (en) * 2005-05-16 2010-04-20 Diane Wright Hoffpauer Fortified cereal bran to promote digestive health
US20070116695A1 (en) * 2005-09-21 2007-05-24 Fallon Joan M Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
US20080160151A1 (en) * 2006-12-29 2008-07-03 Bary Lyn Zeller Method for Preparing Beverage Compositions Having Improved Aroma Release Characteristics and Compositions for Use Therein
US8424541B2 (en) * 2007-07-16 2013-04-23 Philip Morris Usa Inc. Tobacco-free oral flavor delivery pouch product
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
KR101510308B1 (ko) * 2008-09-08 2015-04-08 주식회사 엘지생활건강 트랜스글루타미나제 및 천초목 추출물을 함유하는 손상 모발 회복 조성물
IT1400821B1 (it) * 2009-03-09 2013-07-02 Probiotical Spa Sospensione oleosa contenente batteri probiotici per uso pediatrico
BRPI1010548A2 (pt) 2009-05-11 2016-03-15 Us Smokeless Tobacco Co compósito flavorizante encapsulado, compósito de adoçante artificial encapsulado e produto.
IT1401460B1 (it) * 2010-06-11 2013-07-26 Probiotical Spa "ceppi di batteri probiotici produttori di vitamina b12"
EP2616048A4 (en) 2010-11-19 2014-04-02 Curemark Llc PREPARATION AND USE OF A COMBINATION FREEZING SYSTEM FOR ENZYMES AND GASTROINTESTINAL MODULATORS
WO2013103746A1 (en) 2012-01-03 2013-07-11 Curemark, Llc Methods of treating behavioral symptoms of neurological and mental disorders
US9963488B2 (en) 2012-02-27 2018-05-08 Oragenics, Inc. Variants of the lantibiotic MU1140 and other lantibiotics with improved pharmacological properties and structural features
WO2013192413A1 (en) 2012-06-20 2013-12-27 Mishra Munmaya K Smokeless tobacco comprising lipid granules
JP2017512613A (ja) * 2014-03-20 2017-05-25 ウルトラデント プロダクツ インコーポレイテッド 犠牲組成物を含む包装システム
CN118660635A (zh) * 2021-10-29 2024-09-17 玉米产品开发公司 用于使用转谷氨酰胺酶获得来自剪切的植物蛋白质的胶凝植物蛋白质组合物的方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB825480A (en) * 1957-07-13 1959-12-16 Johann Carl Pflueger Improvements in or relating to ingestible dry micro-organism preparations and method for producing the same
BE757727A (fr) * 1969-10-22 1971-04-20 Balchem Corp Procede d'encapsulation
US3857964A (en) 1973-02-09 1974-12-31 Brook D Controlled release flavor compositions
JPS5231981A (en) * 1975-08-18 1977-03-10 Takeda Chem Ind Ltd Microcapsule preparation method
US4232047A (en) * 1978-05-30 1980-11-04 Griffith Laboratories U.S.A., Inc. Food supplement concentrate in a dense glasseous extrudate
US4576826A (en) 1980-11-03 1986-03-18 Nestec S. A. Process for the preparation of flavorant capsules
JPS5526807A (en) * 1978-08-14 1980-02-26 Norio Tanaka Powdery perfume
PH18554A (en) 1981-07-21 1985-08-09 Unilever Nv Encapsulation of volatile liquids
US4532145A (en) 1983-12-19 1985-07-30 General Foods Corporation Fixing volatiles in an amorphous substrate and products therefrom
US4689235A (en) * 1984-01-31 1987-08-25 Scm Corporation Encapsulation matrix composition and encapsulate containing same
US4828857A (en) 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US5004595A (en) 1986-12-23 1991-04-02 Warner-Lambert Company Multiple encapsulated flavor delivery system and method of preparation
US5009900A (en) * 1989-10-02 1991-04-23 Nabisco Brands, Inc. Glassy matrices containing volatile and/or labile components, and processes for preparation and use thereof
US5209879A (en) 1990-04-06 1993-05-11 Redding Bruce K Method for inducing transformations in waxes
WO1993018667A1 (en) 1992-03-20 1993-09-30 Church & Dwight Company, Inc. Encapsulated dietary fatty acid salt products
US5792505A (en) 1992-09-22 1998-08-11 Mccormick & Company, Inc. Flavor encapsulation
US5601865A (en) 1992-09-22 1997-02-11 Mccormick & Company, Inc. Flavor encapsulation
US5607708A (en) 1992-12-14 1997-03-04 Hunt-Wesson, Inc. Encapsulated volatile flavoring materials
JPH08509018A (ja) 1993-04-16 1996-09-24 マコーミック アンド カンパニー，インク． カプセル化組成物
CH687053A5 (fr) 1993-10-05 1996-09-13 Crina Additifs pour l'alimentation animale et procédé pour leur préparation.
US5506353A (en) 1994-03-21 1996-04-09 Firmenich Sa Particulate hydrogenated starch hydrolysate based flavoring materials and use of same
US5399368A (en) 1994-09-06 1995-03-21 Nestec S.A. Encapsulation of volatile aroma compounds
DE4432905C2 (de) 1994-09-15 1996-07-18 Immuno Gmbh Verfahren zur Bestimmung von freiem Apoprotein (a)
CA2200849A1 (en) * 1994-09-29 1996-04-04 Charles V. Fulger Flavor encapsulation
US5580593A (en) 1995-02-01 1996-12-03 Nestec S.A. Process for making encapsulated sensory agents
US5496574A (en) 1995-02-01 1996-03-05 Nestec S.A. Encapsulated sensory agents
US5736178A (en) 1995-05-02 1998-04-07 Opta Food Ingredients, Inc. Colloidal dispersions of gluten, method of making and use therefor
US5756136A (en) 1995-06-02 1998-05-26 Mccormick & Company, Inc. Controlled release encapsulation compositions
FR2750997B1 (fr) * 1996-07-12 2003-04-25 Rhone Poulenc Chimie Granules d'un produit parfume a liberation controlee, leur procede d'obtention et leur utilisation dans les compositions detergentes pour lave-vaisselle
US6500463B1 (en) * 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles

Cited By (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9624526B2 (en) 1999-12-17 2017-04-18 Curemark Llc Method for treating pervasive development disorders
US9624525B2 (en) 1999-12-17 2017-04-18 Curemark, Llc Method for treating pervasive development disorders
US10209253B2 (en) 2000-11-16 2019-02-19 Curemark, Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
JP2006527739A (ja) * 2003-06-18 2006-12-07 リポフーズ，エセ．エレ． 活性成分の投与のためのマイクロカプセル
JP2007532543A (ja) * 2004-04-07 2007-11-15 レスベラトロル パートナーズ， エルエルシー 栄養補助サプリメントおよびそれを処理する方法
KR101213141B1 (ko) * 2004-04-07 2012-12-17 레스베라트롤 파트너스, 엘엘씨 건강보조식품과 그 제조방법
JP2008510695A (ja) * 2004-08-20 2008-04-10 フイルメニツヒ ソシエテ アノニム フレーバー又はフレグランス成分又は組成物を炭水化物マトリックス中に導入する方法
US10350229B2 (en) 2005-08-30 2019-07-16 Curemark, Llc Use of lactulose in the treatment of autism
US11033563B2 (en) 2005-08-30 2021-06-15 Curemark, Llc Use of lactulose in the treatment of autism
US9925250B2 (en) 2008-03-13 2018-03-27 Curemark, Llc Method of treating proteinuria in pregnancy
US11045527B2 (en) 2008-03-13 2021-06-29 Curemark, Llc Method of diagnosing preeclampsia or pregnancy-induced hypertension
US9687534B2 (en) 2008-04-18 2017-06-27 Curemark, Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
US11235038B2 (en) 2008-04-18 2022-02-01 Curemark, Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
US10272141B2 (en) 2008-04-18 2019-04-30 Curemark, Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
US10588948B2 (en) 2008-06-26 2020-03-17 Curemark, Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US11016104B2 (en) 2008-07-01 2021-05-25 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
JP2012503474A (ja) * 2008-09-24 2012-02-09 ボングレン エス．アー． チーズ又はチーズ製品を製造する方法及び装置
US9687535B2 (en) 2008-10-03 2017-06-27 Curemark, Llc Methods and compositions for the treatment of symptoms of prion diseases
US10413601B2 (en) 2008-10-03 2019-09-17 Curemark, Llc Methods and compositions for the treatment of symptoms of prion diseases
JP2010090195A (ja) * 2008-10-03 2010-04-22 Mohan Sharad 固形石鹸及びこれを用いた送達方法
US10736946B2 (en) 2009-01-06 2020-08-11 Galenagen, Llc Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces
US9895427B2 (en) 2009-01-06 2018-02-20 Galenagen, Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
US11357835B2 (en) 2009-01-06 2022-06-14 Galenagen, Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
JP2015205892A (ja) * 2009-04-13 2015-11-19 キュアマーク リミテッド ライアビリティ カンパニー 酵素送達システムならびに調製方法および使用方法
US9931302B2 (en) 2009-04-13 2018-04-03 Curemark , LLC Enzyme delivery systems and methods of preparation and use
US11419821B2 (en) 2009-04-13 2022-08-23 Curemark, Llc Enzyme delivery systems and methods of preparation and use
JP2017197573A (ja) * 2009-04-13 2017-11-02 キュアマーク リミテッド ライアビリティ カンパニー 酵素送達システムならびに調製方法および使用方法
US9687452B2 (en) 2009-04-13 2017-06-27 Curemark, Llc Enzyme delivery systems and methods of preparation and use
JP2012523462A (ja) * 2009-04-13 2012-10-04 キュアマーク リミテッド ライアビリティ カンパニー 酵素送達システムならびに調製方法および使用方法
US10098844B2 (en) 2009-04-13 2018-10-16 Curemark, Llc Enzyme delivery systems and methods of preparation and use
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
JP2012055288A (ja) * 2010-09-13 2012-03-22 Kaneka Corp 安定化された生菌製剤およびその製造方法。
US10940187B2 (en) 2011-04-21 2021-03-09 Curemark, Llc Method of treatment of schizophreniform disorder
US10279016B2 (en) 2011-04-21 2019-05-07 Curemark, Llc Method of treatment of schizophreniform disorder
US8916528B2 (en) 2011-11-16 2014-12-23 Resveratrol Partners, Llc Compositions containing resveratrol and nucleotides
US9226937B2 (en) 2011-11-16 2016-01-05 Resveratrol Partners, Llc Compositions containing resveratrol and nucleotides
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US11364287B2 (en) 2012-05-30 2022-06-21 Curemark, Llc Methods of treating celiac disease
KR101804284B1 (ko) * 2015-09-24 2017-12-14 학교법인연세대학교 프로바이오틱 유산균을 함유하는 우유과자의 제조방법
US12226464B2 (en) 2017-04-10 2025-02-18 Curemark, Llc Compositions for treating addiction
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
US12485094B2 (en) 2020-09-10 2025-12-02 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Also Published As

Publication number Publication date
WO2001045835A1 (en) 2001-06-28
AU2090801A (en) 2001-07-03
MXPA02006202A (es) 2003-09-25
AU780513C (en) 2006-09-07
KR20020095172A (ko) 2002-12-20
EP1433525A1 (en) 2004-06-30
US6251478B1 (en) 2001-06-26
CA2394520A1 (en) 2001-06-28
USRE40059E1 (en) 2008-02-12
CN1413125A (zh) 2003-04-23
EP1242174A1 (en) 2002-09-25
NZ519521A (en) 2004-10-29
AU780513B2 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
JP2003517831A (ja) 感受性物質のカプセル化
Balassa et al. Microencapsulation in the food industry
EP2588066B1 (en) Solid core coacervated capsules
RU2359662C2 (ru) Микрокапсулы
CN101252845B (zh) 胶囊化活性成分、制备方法及其用途
EP0169893A1 (en) Encapsulation matrix composition and encapsulate containing same
JPS585139A (ja) バタ−風味油
CN101516492B (zh) 胶囊
CN1925908A (zh) 微胶囊
US2897119A (en) Stable powdered oil soluble vitamins and method of preparing stable powdered oil soluble vitamins
WO1999052511A1 (en) Tarch capsules containing microorganisms and/or polypeptides or proteins and a process for producing them
JPH06181725A (ja) 易酸化性油状物の固形化剤
JPH0482827A (ja) 腸溶性カプセル
CN110859297A (zh) 一种制备耐水煮缓释香精油微胶囊的方法
US3067105A (en) Vitamin compositions and processes for producing same
HK1051982A (en) Sensitive substance encapsulation
JP2857885B2 (ja) 顆粒化粉末の製造法
JPS6137051A (ja) カプセルを含有した食用液状油組成物
Rokhmah et al. Essential Fatty Acid, Phospholipids, and Morphological Characteristics of Bone Marrow Microcapsules.
JPS633769A (ja) ロ−ヤルゼリ−を含有するマイクロカプセルの製造方法
JPH0283031A (ja) マイクロカプセルの製造方法
JP2001161306A (ja) 嗜好性に優れたゼラチンカプセルの製法
Barbosa Novel Delivery Systems for Ascorbic Acid Release in Food Matrices
JPS60141234A (ja) カプセルを含有した食用液状油組成物
Nussinovitch Liquid-core beads and their applications in food, biotechnology, and other fields

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071213

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071213

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080919

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090406

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090910